DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163143

Prevalence of anti-hepatitis C virus antibodies among indoor patients and blood donors attending a tertiary care hospital in North India

Noor Jahan, Vijay Gupta, Mariyam Sana, Sudhir Mehrotra, Razia Khatoon

Abstract


Background: Hepatitis C virus (HCV) causes acute as well as chronic hepatitis such as cirrhosis of liver and hepatocellular carcinoma. The virus is mainly transmitted through blood and blood products. Hence, in order to provide safe blood supply testing of each blood unit for markers of HCV has been made mandatory. The infection is detected by the presence of anti-HCV antibody in the patient’s serum. The objective of the present study was to determine the prevalence of anti-HCV antibodies among indoor patients and blood donors.

Methods: A hospital based cross-sectional study was done from January to June 2016. A total of 1991 subjects comprising of 1649 indoor patients and 342 blood donors were included in the study whose blood samples were screened for presence of anti-Hepatitis C antibody using rapid HCV TRI-DOT and HCV Microlisa.

Results: Out of 1649 indoor patients tested, 39 were found to be reactive, and out of 342 blood donors tested, 4 were found to be reactive, hence, the prevalence of anti-HCV antibody was found to be 2.4% among indoor patients and 1.2% among blood donors. The seroprevalence of anti-HCV antibody was found to be more among replacement donors (1.2%) as compared to voluntary donors (1.1%).

Conclusions: As blood transfusion is an important mode of transmission of HCV, hence, prevention in the form of proper screening of every unit of blood prior to transfusion is mandatory. As voluntary donors are relatively safe, this should be encouraged by organizing frequent blood donation camps.

 


Keywords


Anti-HCV antibody, Prevalence, HCV TRI-DOT, HCV Microlisa, Patients, Blood donors

Full Text:

PDF

References


Makroo RN, Walia RS, Chowdhry M, Bhatia A, Hegde V, Rosamma NL. Seroprevalence of anti-HCV antibodies among blood donors of north India. Indian J Med Res. 2013;138:125-8.

Karki S, Ghimire P, Tiwari BR, Maharjan A, Rajkarnikar M. Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors. Jpn J Infect Dis. 2008;61:324-6.

Gupta S, Kumar R, Kaur A. Prevalence of hepatitis C virus seropositivity among blood donors in a Tertiary Care Hospital. Int Res J Med Sci. 2015;3:22-4.

Baheti R, Gehlot RS, Baheti R. Seroprevalence of Anti HCV Ab in healthy voluntary blood donors and in high risk individuals. J Indian Assoc Community Med. 2000;1:230-2.

Tandon BN. Hepatitis B and C: a holistic approach. Gastroenterol Today. 2002;6:168-9.

Widmann FK. Technical manual american association of blood banks. Aglington Ust. 1985:325-44.

Jain A, Rana SS, Chakravarty P, Gupta RK, Murthy NS, Nath MC. The prevalence of Hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. European J Epidemiol. 2003;18:695-7.

Sood S, Malvankar S. Seroprevalence of Hepatitis B surface antigen, antibodies to the Hepatitis C virus, and Human Immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan. Indian J Comm Med. 2010;35:165-9.

Pears E. Hepatitis C virus infection: risk factors, diagnosis and management. Nurs Stand. 2010;25:15-7.

Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. Transfusion-transmitted infections. J Transl Med. 2007;5:25-7.

Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat. 2002;9:84-100.

Singh B, Verma M, Verma K. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis. 2004;57:49-51.

Wilkins T, Malcolm JK, Raina D, Schade RR. Hepatitis C. Diagnosis and treatment. Am Fam Physician. 2010;81:1351-7.

Mittal G, Gupta P, Gupta R, Ahuja V, Mittal M, Dhar M. Seroprevalence and risk factors of Hepatitis B and Hepatitis C virus infections in Uttarakhand, India. J Clin Exp Hepatol. 2013;3:296-300.

Deshpande RH, Wadde SK. Seroprevalence of HCV in blood donors status of blood donors seropositivity of HCV in marathwada, India. J Pharma Biomed Sci. 2012;23:1-4.

Mishra S, Chayani N, Sarangi G, Mallick B, Pati SB. Seroprevalence of anti-HCV antibody in and around Cuttack, Orissa. Indian J Med Microbiol. 2002;20:40-1.

Sharma R, Sinha P, Bachiwal R, Rishi S. Seroprevalence of anti-hepatitis C virus antibodies in a hospital based population in Jaipur, Rajasthan. Indian J Community Med. 2007;32:158-9.

Bhattacharya S, Badrinath S, Hamide A, Sujatha S. Seroprevalence of hepatitis C virus in a hospital based general population in South India. Indian J Med Micobiol. 2003;21:43-5.

Rajani M, Jais M. Age-wise seroprevalence of hepatitis C virus infection in clinically suspected infectious hepatitis patients attending a tertiary care hospital in Delhi. Int J Med Public Health. 2014;4:78-81.

Chu CJ, Hussain M, Lok ASF. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology. 2002;122:1756-62.

Makroo RN, Raina V, Kaushik V. Prevalence of hepatitis C virus antibody in healthy blood donors. Indian J Med Res. 1999;110:123-5.

Choudhury N, Ramesh V, Saraswat S, Naik S. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian J Med Res. 1995;101:229-32.

Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol. 2001;44:409-12.

Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res. 2006;124:431-8.

Rawat V, Bhatt U, Singhai M, Kumar A, Malik YPS. Prevalence of hepatitis C virus infection among blood donors of Kumaon region of Uttarakhand. Indian J Med Microbiol. 2013;31:313-4.